Hitesh K. Jindal

Tecan (United Kingdom)

Papers

1

Total Citations

4

H-Index

1

About

Hitesh K. Jindal is a distinguished researcher whose work lies at the critical intersection of microfluidics and early-stage drug discovery. His key contributions center on developing and validating high-throughput screening platforms for assessing ADME/Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties—a vital step in identifying viable drug candidates. Jindal’s most notable work, published in 2003, demonstrated the application of Tecan’s LabCD-ADMET system for evaluating Cytochrome P450 Inhibition, Serum Protein Binding, and P-glycoprotein Interaction. This research provided a proof-of-concept for integrating complex biological assays onto a compact, centrifugal microfluidic disc, paving the way for faster, more efficient preclinical screening. While his highly specialized work has garnered focused citations, its impact is significant within the microfluidics and pharmaceutical assay communities, establishing a foundational methodology for lab-on-a-chip ADMET profiling. Jindal’s contributions are particularly valuable for students and researchers interested in the practical application of microfluidic technologies to solve real-world bottlenecks in drug development.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
ADMET Assays on Tecan's LabCD-ADMET System
4 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Tecan (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago